Core Viewpoint - The Hong Kong stock market is becoming increasingly active, with a notable rise in IPOs compared to previous years. However, the recent IPO of the internet technology company, Shouhui Group, has faced significant challenges, including a drop in stock price shortly after listing, indicating potential issues with its business model and market reception [2][5]. Company Overview - Shouhui Group is a personal insurance intermediary service provider that utilizes an online platform to offer insurance solutions to policyholders and insurers. The company primarily generates revenue through three main business segments: Niubao 100, Xiaoyusan, and Kachabao, with over 60% of its revenue coming from Niubao 100 [5][9][10]. Market Position - In 2023, the total premium of China's personal insurance market reached RMB 3.8 trillion, with the personal insurance intermediary market totaling RMB 237 billion, accounting for 6.3% of the overall market. Shouhui Group ranked eighth in the domestic personal insurance intermediary market with a market share of 2.9% [6][7]. Financial Performance - Shouhui Group's revenue fluctuated significantly from 2021 to 2024, with reported revenues of RMB 1.548 billion, RMB 806 million, RMB 1.634 billion, and RMB 1.387 billion, respectively. The company experienced net losses in 2021 and 2023, while achieving profitability in 2022 [8][19]. Revenue Breakdown - The revenue contributions from the three business segments are as follows: Niubao 100 contributed 67.6% in 2023, Xiaoyusan contributed 19.5%, and Kachabao contributed 12.9%. Niubao 100 is primarily driven by external traffic from media and licensed brokers [15][14]. Cost Structure - The main costs for Shouhui Group include commissions paid to insurance agents and brokers, channel promotion expenses, and employee salaries. Commissions accounted for 55.8% of total costs in 2024 [20][21]. Marketing Strategy - The company has maintained a high marketing expenditure, with over 40% of sales and marketing costs allocated to advertising and promotions in the past three years. In 2024, the total channel expenses reached RMB 801 million, significantly overshadowing the RMB 51 million spent on research and development [23][21]. Market Challenges - The competitive landscape for Shouhui Group is intense, with competition from other intermediaries, banks, and insurance agencies. The reliance on online traffic for customer acquisition poses challenges, especially in a market that increasingly demands profitability over growth [7][25].

Group 1 - The core point of the article is that Shenzhen Shouhui Technology Group Co., Ltd. has successfully passed the listing hearing on the Hong Kong Stock Exchange after multiple attempts, but faces significant challenges ahead, including financial losses and market competition [2][9]. - The company issued 24.36 million new shares at a price of HKD 8.08 per share, raising a total of HKD 197 million, but the stock price fell significantly on its debut, closing at HKD 6.61, a drop of 18.19% [2][3]. - The company has experienced substantial financial volatility, with revenues of HKD 8.06 billion in 2022, HKD 16.34 billion in 2023 (a 102.7% increase), and a drop to HKD 13.87 billion in 2024 (a 15.1% decrease) [5][6]. Group 2 - The company has accumulated losses of HKD 4.92 billion over the years 2023 and 2024, with net losses of HKD 3.56 billion in 2023 and HKD 1.36 billion in 2024 [5][6]. - The revenue structure is heavily reliant on insurance transaction commissions, with over 99% of income derived from this source, indicating a vulnerability in its business model [6][7]. - Approximately 60% of the funds raised from the IPO are intended for optimizing the sales network and research and development, highlighting the company's focus on improving operational efficiency [7][8]. Group 3 - The company has faced internal governance issues, including a notable incident in 2020 involving a power struggle among founders, which raises concerns about management stability [8][9]. - The company operates under significant pressure from investor agreements that could lead to substantial financial liabilities if it fails to meet certain milestones [7][8]. - The competitive landscape is challenging, with major players like Ant Group and Tencent exerting pressure on smaller platforms, necessitating strategic adaptations for future growth [9].

Core Viewpoint - Handback Technology Group successfully listed on the Hong Kong Stock Exchange after two previous failed attempts, raising approximately HKD 134 million through its IPO [2]. Company Overview - Handback Technology Group, established in 2015, is an insurance intermediary service provider that operates three online platforms: "Little Umbrella," "Kacha Insurance," and "Niu Bao 100," which facilitate direct distribution, agent distribution, and partner distribution of insurance products [2][3]. - The company aims to cover the entire lifecycle of insurance products, offering various plans such as children's critical illness insurance and adult critical illness insurance [4]. Financial Performance - The company reported revenues of RMB 1.548 billion, RMB 806 million, RMB 1.634 billion, and RMB 1.387 billion for the years 2021 to 2024, respectively [4]. - Net profit figures show a loss of RMB 204 million in 2021, a profit of RMB 131 million in 2022, and losses of RMB 356 million and RMB 136 million in 2023 and 2024, respectively [4]. - Adjusted net profits (non-HKFRS) were RMB 75 million, RMB 253 million, and RMB 242 million for 2022, 2023, and 2024, respectively [4]. Market Position - In 2023, the total premium of China's personal insurance intermediary market reached RMB 237 billion, with Handback Group ranking eighth and holding a market share of 2.9% [3]. - Handback Group is the second-largest online insurance intermediary in China, with a market share of 7.3% in the long-term personal insurance segment based on total premiums [3]. Industry Context - The implementation of the "reporting and operation integration" policy has compressed commission margins, significantly impacting insurance intermediaries [5]. - The tightening of regulations is forcing industry players to invest heavily in technology and compliance [5].

Group 1: Hand Return Group - Hand Return Group plans to list on the Hong Kong Stock Exchange on May 30, 2025, with the stock code "2621" [3] - The IPO will issue a total of 24,358,400 shares, with a subscription rate of 990 times for the Hong Kong public offering and 1.13 times for the international offering [3] - The company aims to provide insurance service solutions through its online platform, with three main platforms: Xiao Yusan, Kachaba, and Niu Bao 100 [3] - Hand Return Group is the second-largest online insurance intermediary in China, holding a 7.3% market share in long-term life insurance premiums as of 2023 [4] - The company has distributed over 1,900 products since its establishment, including more than 280 customized products [4] - Financial data shows revenues of 806 million, 1.634 billion, and 1.387 billion CNY from 2022 to 2024, with adjusted net profits of 75 million, 253 million, and 242 million CNY respectively [5] Group 2: Yingshi Innovation - Yingshi Innovation plans to open subscriptions on May 30, 2025, and is expected to list on the Sci-Tech Innovation Board in mid-June [7] - The company will issue 41 million new shares, with 20% allocated for strategic placement [7] - Yingshi Innovation specializes in smart imaging devices, focusing on panoramic and action cameras, with a global market share of 67.2% in panoramic cameras as of 2023 [8] Group 3: Lin Qingxuan - Lin Qingxuan submitted its prospectus to the Hong Kong Stock Exchange on May 29, 2025, aiming for a main board listing [10] - The brand ranks first among domestic high-end skincare brands in China by retail sales as of 2024 [11] - Financial data indicates revenues of 691 million, 805 million, and 1.21 billion CNY from 2022 to 2024, with a compound annual growth rate of 32.5% [11] Group 4: Yushi Technology - Yushi Technology submitted its prospectus on May 28, 2025, planning to list on the Hong Kong Stock Exchange [14] - The company is the largest supplier of L4-level autonomous driving solutions for airport and factory scenarios in Greater China as of 2024 [15] - Financial data shows revenues of 66 million, 161 million, and 266 million CNY from 2022 to 2024, with a compound annual growth rate of 101.3% [15] Group 5: Yisiwei Computing - Yisiwei Computing submitted its prospectus on May 30, 2025, aiming for a main board listing [19] - The company is a leading provider of RISC-V solutions in China, with over 100 system-level solutions commercialized as of 2024 [20] - Financial data indicates revenues of 2 billion, 1.752 billion, and 2.025 billion CNY from 2022 to 2024 [20] Group 6: Xian Gong Intelligent - Xian Gong Intelligent submitted its prospectus on May 27, 2025, planning to list on the Hong Kong Stock Exchange [22] - The company ranks first in global robot controller sales for two consecutive years, with a market share of 23.6% in 2024 [22] - Financial data shows revenues of 184 million, 249 million, and 339 million CNY from 2022 to 2024, with a compound annual growth rate of 35.7% [23] Group 7: Tuopu CNC - Tuopu CNC submitted its prospectus on May 26, 2025, aiming for a main board listing [27] - The company is the top supplier of five-axis CNC machine tools in China's aerospace market, with an 11.6% market share as of 2024 [29] - Financial data indicates revenues of 136 million, 335 million, and 531 million CNY from 2022 to 2024, with a compound annual growth rate of 97.9% [29] Group 8: Xiantong Pharmaceutical - Xiantong Pharmaceutical submitted its prospectus on May 26, 2025, planning to list on the Hong Kong Stock Exchange [32] - The company is the first in China to obtain approval for innovative radioactive drugs, focusing on oncology and neurodegenerative diseases [32] Group 9: Ledong Robotics - Ledong Robotics submitted its prospectus on May 30, 2025, aiming for a main board listing [35] - The company has a customer retention rate of approximately 90% in 2024, with a compound annual growth rate of about 41.4% in revenues from 2022 to 2024 [36] Group 10: Saintong Special Medical - Saintong Special Medical submitted its prospectus on May 30, 2025, planning to list on the Hong Kong Stock Exchange [38] - The company ranks first among domestic special medical food brands in China, with a market share of 6.3% as of 2024 [39] - Financial data shows revenues of 491 million, 654 million, and 834 million CNY from 2022 to 2024, with a compound annual growth rate of 30.3% [39] Group 11: Jushuitan - Jushuitan updated its prospectus on May 22, 2025, continuing its listing process on the Hong Kong Stock Exchange [41] - The company is the largest e-commerce SaaS ERP provider in China, holding a 24.4% market share as of 2024 [42] - Financial data indicates revenues of 523 million, 697 million, and 910 million CNY from 2022 to 2024, with a compound annual growth rate of 31.9% [42]

Core Viewpoint - The insurance intermediary company, Shouhui Group, has successfully listed on the Hong Kong Stock Exchange but faces challenges with its stock price dropping significantly post-IPO, reflecting broader issues in the insurance intermediary sector regarding sustainability and profitability [1][2]. Group 1: IPO Performance - Shouhui Group's IPO price was HKD 8.08, raising nearly HKD 200 million by issuing 24,358,400 shares. However, the stock closed at HKD 6.61 on the first trading day, marking an 18.19% decline [1]. - Other insurance intermediaries, such as Yuanbao and Huize, have also experienced post-IPO stock price declines, indicating a trend of "breaking the issue" in the sector [1][2]. Group 2: Revenue and Profitability Challenges - Shouhui Group's revenue is primarily derived from commission income, which accounted for over 99% of total revenue during the reporting period. The commission income figures were CNY 15.45 billion, CNY 8.02 billion, CNY 16.29 billion, and CNY 13.78 billion for the respective years [3]. - The company reported net profits of -CNY 2.04 billion, CNY 1.31 billion, -CNY 3.56 billion, and -CNY 1.36 billion from FY2021 to FY2024, highlighting significant volatility in profitability [2][4]. Group 3: Market Trends and Regulatory Impact - The "reporting and operation integration" policy has significantly impacted the intermediary channel, leading to concerns about the sustainability of the insurance intermediary business model. This policy has resulted in a mandatory reduction of sales commissions by 40% to 50% [2][4]. - The trend of "de-intermediation" is increasing, with traditional insurance companies establishing their online platforms to sell insurance products directly to customers, putting pressure on insurance intermediaries [2]. Group 4: Investment Landscape - The insurance technology sector has seen a surge in IPOs, with several companies, including Shouhui Group, going public amid pressures from early investors seeking exits. Many of these companies were established around 2015 during the rise of internet insurance [6][8]. - The investment landscape has shifted, with early investors facing exit pressures as many companies enter their 5-7 year investment recovery period [6][7].

Core Viewpoint - The article highlights the strong market interest in Shouhui Group's IPO, with a subscription rate of nearly 990 times for public offerings, indicating high investor demand [1][4]. Group 1: IPO Details - Shouhui Group's public offering received a subscription level of 990 times, while the international offering had a subscription level of 1.13 times [2][3]. - The final offering price was set at the upper limit of the range at 8.08 HKD, with the price range being 6.48 HKD to 8.08 HKD [3]. - The total number of shares available for public offering was 2,436,000, with a final allocation of 12,179,200 shares after redistribution from the international offering [2][3]. Group 2: Market Position and Business Model - In 2023, Shouhui Group held a 7.3% market share in China's online insurance intermediary market, making it the second-largest player in this sector [6][7]. - The company operates through three main platforms: Xiaoyusan, Kachabao, and Niubao100, which cover direct sales, agent distribution, and business partner distribution [5][6]. - Shouhui Group has established partnerships with over 110 insurance companies and has distributed more than 1,900 insurance products [7]. Group 3: Financial Performance - Shouhui Group's revenue for 2022, 2023, and projected for 2024 were 806 million, 1.634 billion, and 1.387 billion RMB respectively, showing stable profitability in core operations [7]. - The adjusted profits for the same years were 75 million, 253 million, and 242 million RMB, indicating consistent profit generation [7]. Group 4: Strategic Outlook - The company plans to enhance its service quality and efficiency by collaborating with more industry participants and investing in product innovation [13]. - Shouhui Group aims to improve its digital platform and operational efficiency through increased R&D and technology investments [13]. - The company is also exploring opportunities for mergers, acquisitions, and international expansion to diversify its business [13]. Group 5: Founders and Backing - The founders of Shouhui Group have prior experience at Tencent, which has influenced the company's focus on digitalization [10][11]. - The company has attracted significant investment from well-known institutions, achieving a valuation of 1.2 billion RMB after its latest funding round [11].

Group 1 - The core point of the article is that Shenzhen Shouhui Technology Group Co., Ltd. (Shouhui Group) successfully listed on the Hong Kong Stock Exchange after two previous failed attempts, marking a significant milestone for the company [1] - Shouhui Group's global offering consisted of 24.3584 million shares, with 12.1792 million shares allocated for both the Hong Kong public offering and international offering, at a final price of HKD 8.08 per share [1] - The company was founded in 2015 and operates as a life insurance intermediary service provider, primarily generating revenue from commissions paid by insurance companies [1] Group 2 - According to Frost & Sullivan, Shouhui Group ranks eighth in the Chinese life insurance intermediary market with a market share of 2.9%, and it is the second-largest online insurance intermediary in China with a market share of 7.3% based on long-term life insurance premiums in 2023 [2] - Shouhui Group's revenue from 2021 to 2024 was reported as follows: CNY 1.548 billion, CNY 806 million, CNY 1.634 billion, and CNY 1.387 billion, respectively [3] - The company experienced a net loss of CNY 204 million in 2021, a profit of CNY 131 million in 2022, and losses of CNY 356 million and CNY 136 million in 2023 and 2024, respectively, while adjusted net profits were CNY 75 million, CNY 253 million, and CNY 242 million for the same years [3] Group 3 - Shouhui Group's business model consists of three digital platforms: the direct-to-consumer platform "Little Umbrella," the agent-enabled distribution platform "Kacha Insurance," and the B2B distribution platform "Niu Insurance 100" [3] - In 2024, the online direct distribution revenue from "Little Umbrella" was CNY 293 million, accounting for 21.3% of the total insurance transaction service revenue; "Kacha Insurance" generated CNY 220 million, representing 15.9%; and "Niu Insurance 100" contributed CNY 865 million, making up 62.8% of the total [3]

Core Viewpoint - Hand Return Group Limited (referred to as "Hand Return Group") was listed on the Hong Kong Stock Exchange, opening at HKD 7.5 and closing at HKD 6.61, reflecting a decline of 18.19% from its opening price [1]. Summary by Relevant Sections Share Issuance and Capital Structure - The total number of shares issued by Hand Return Group was 24,358,400, with 12,179,200 shares allocated for public offering in Hong Kong and 12,179,200 shares for international offering [2]. - The number of shares outstanding at the time of listing, before the exercise of the over-allotment option, was 226,378,600 [2]. Pricing and Proceeds - The final offer price was set at HKD 8.08, resulting in total proceeds of HKD 196.82 million. After deducting estimated listing expenses of HKD 62.59 million, the net proceeds amounted to HKD 134.22 million [4][5]. Business Overview - Hand Return Group is a Chinese life insurance intermediary service provider, focusing on providing insurance service solutions through its digital transaction and service platforms, including Xiao Yu San, Ka Cha Bao, and Niu Bao 100 [6]. - The funds raised are expected to be utilized over the next 60 months to enhance and optimize the company's sales and marketing network, improve services, boost research and development capabilities, and for selected mergers and acquisitions [6]. Financial Performance - Projected revenues for Hand Return Group are as follows: RMB 806.26 million in 2022, RMB 1.634 billion in 2023, and RMB 1.387 billion in 2024. The net profits (losses) for the same years are projected to be RMB 131 million, -RMB 356 million, and -RMB 136 million respectively [7]. - The operating cash flow for 2022 was -RMB 54.26 million, while it is projected to be RMB 205.07 million in 2023 and RMB 110.1 million in 2024 [8].

Group 1 - The core viewpoint of the article is that Hand Return Group, a personal insurance intermediary service provider, has officially launched its IPO, planning to issue approximately 24.36 million shares at a price range of HKD 5.84 to HKD 8.08, with a listing date set for May 30 on the Hong Kong Stock Exchange [2] - The global offering consists of about 90% international placement (approximately 21.92 million shares) and 10% for public offering in Hong Kong (approximately 2.44 million shares), with cornerstone investors Tianjin Haitai Group and Luch Capital subscribing for a total of approximately HKD 49.55 million [2] - Based on the median issue price of HKD 7.28, the company's market capitalization post-listing is estimated to be around HKD 1.648 billion (approximately RMB 1.517 billion), with a price-to-sales (PS) ratio of 1.09 and a price-to-earnings (PE) ratio of 6.27 [2] Group 2 - According to the prospectus, Hand Return Group's revenue for 2022, 2023, and 2024 is projected to be RMB 806 million, RMB 1.634 billion, and RMB 1.387 billion, respectively, with adjusted net profits of RMB 75 million, RMB 253 million, and RMB 242 million, indicating a rising adjusted net profit margin reaching 17.4% by 2024 [3] - The company utilizes a digital platform to provide personal insurance transaction and service solutions, operating three major platforms: Xiao Yusan (online direct sales), Kachabao (agent distribution), and Niubao 100 (partner distribution), with over 1,900 insurance products distributed by the end of 2024 [3] - In 2023, the scale of personal insurance premiums in China reached RMB 500 billion, accounting for 14.6% of the total personal insurance market premiums, although the performance of insurance technology and intermediary platforms in the capital market has been mixed [3]

Core Viewpoint - Shenzhen Shouhui Technology Group Co., Ltd. has successfully passed the main board listing hearing on the Hong Kong Stock Exchange after multiple attempts, marking a significant step in its 18-month IPO journey [1][4]. Group 1: IPO Details - The company plans to globally offer 24.3584 million shares, with 22 million shares for international offering and 2.436 million shares for public offering in Hong Kong, at a price range of HKD 5.84 to HKD 8.08, aiming to raise up to HKD 196.8 million [1][3]. - The listing is expected to commence trading on May 30 [1]. Group 2: Financial Performance - The company has experienced significant financial volatility, with revenues of RMB 806 million, RMB 1.634 billion, and RMB 1.387 billion for the years 2022, 2023, and 2024 respectively, showing a 102.7% increase in 2023 followed by a 15.1% decline in 2024 [7]. - Cumulative net losses over two years reached RMB 4.92 billion, with losses of RMB 3.56 billion in 2023 and RMB 1.36 billion in 2024 [7][8]. Group 3: Business Model and Revenue Structure - The company primarily relies on insurance transaction commissions, with over 99% of its revenue coming from this source, while technology service income accounts for less than 1% [8]. - The "Niubao 100" platform contributed 62.8% of total insurance transaction service revenue in 2024, highlighting the vulnerability of its business model [6][8]. Group 4: Market Position and Competition - In 2023, the company held a 7.3% market share in the long-term personal insurance market, making it the second-largest online insurance intermediary in China [5]. - The company faces competition from major players like Ant Group and Tencent, which are pressuring smaller platforms [11]. Group 5: Governance and Internal Challenges - The company has faced internal governance issues, including a notable incident in 2020 involving a power struggle between co-founders, which raised concerns about its management stability [10]. - The company has also faced regulatory penalties for compliance violations, further intensifying investor concerns regarding its internal controls [10]. Group 6: Future Outlook - The company aims to use approximately 60% of the IPO proceeds to optimize its sales network and research and development, while the remaining funds will be allocated for liquidity and acquisitions [9]. - The future performance of the company remains uncertain, as it must navigate industry challenges and internal volatility post-IPO [11].